ORBIMED ADVISORS LLC Insider Trading $PCRX Pacira BioSciences, Inc.
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in AMARIN CORP PLC\UK ($AMRN) and 10% Owner in AMBIT BIOSCIENCES CORP ($AMBI) and 10% Owner in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Anthera Pharmaceuticals Inc ($ANTH) and 10% Owner in COMPLETE GENOMICS INC ($GNOM) and 10% Owner in Pacira Pharmaceuticals, Inc. ($PCRX) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).
ORBIMED ADVISORS LLC in Pacira BioSciences, Inc.
Trading Symbol: PCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 2,446,000 shares
Current Value: $102,120,500
Latest Transaction: Mar 13 2012
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in Pacira BioSciences, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, AMBI, ANTH, GNOM, ICPT, MYG, PCRX, RLYP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 13 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.03 | 700 | 7,722 | 2,446,000 | 2.4 M to 2.4 M (-0.03 %) |
Mar 13 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.03 | 62,400 | 688,384 | 2,446,700 | 2.5 M to 2.4 M (-2.49 %) |
Mar 13 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.25 | 300 | 3,374 | 2,509,100 | 2.5 M to 2.5 M (-0.01 %) |
Mar 13 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.25 | 36,700 | 412,714 | 2,509,400 | 2.5 M to 2.5 M (-1.44 %) |
Feb 29 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.86 | 3,000 | 32,584 | 2,546,100 | 2.5 M to 2.5 M (-0.12 %) |
Feb 29 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.12 | 100 | 1,112 | 2,549,100 | 2.5 M to 2.5 M (0.00 %) |
Feb 29 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.12 | 10,000 | 111,204 | 2,549,200 | 2.6 M to 2.5 M (-0.39 %) |
Feb 29 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.05 | 300 | 3,314 | 2,559,200 | 2.6 M to 2.6 M (-0.01 %) |
Feb 29 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.05 | 28,700 | 317,055 | 2,559,500 | 2.6 M to 2.6 M (-1.11 %) |
Feb 03 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.79 | 500 | 5,395 | 2,588,200 | 2.6 M to 2.6 M (-0.02 %) |
Feb 03 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.79 | 49,500 | 534,125 | 2,588,700 | 2.6 M to 2.6 M (-1.88 %) |
Feb 03 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.85 | 200 | 2,171 | 2,638,200 | 2.6 M to 2.6 M (-0.01 %) |
Feb 03 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 10.85 | 23,100 | 250,746 | 2,638,400 | 2.7 M to 2.6 M (-0.87 %) |
Feb 03 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.01 | 700 | 7,704 | 2,661,500 | 2.7 M to 2.7 M (-0.03 %) |
Feb 03 2012 | PCRX | Pacira Pharmaceuti ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 11.01 | 69,300 | 762,702 | 2,662,200 | 2.7 M to 2.7 M (-2.54 %) |
Page: 1